#VALOR_HCM - Twitter Hashtag

over 3 years ago

17d) In #VALOR_HCM, #mavacamten also ➡️significant improvements in the degree of mitral regurgitation #MR and in systolic motion of the anterior mitral valve leaflet #SAM:

cardiomet_CE's tweet photo. 17d) In #VALOR_HCM, #mavacamten also ➡️significant improvements in the degree of mitral regurgitation #MR and in systolic motion of the anterior mitral valve leaflet #SAM: https://t.co/Y0RLcWOk5S

1

4

1

1K

cardio-met

@cardiomet_CE

over 3 years ago

16a) So, more data: #VALOR_HCM, a #RDBPC trial, aimed to assess #mavacamten in pts w/ #oHCM who were referred for or actively considering septal reduction tx #SRT. Included: 🫀 at least 18 🫀 LV wall thickness ≥ 15 mm (13 mm if familial) 🫀 #NYHA class 3 or higher (2 if syncope)

1

2

0

694

cardio-met

@cardiomet_CE

over 3 years ago

34) Let’s take a quick breather! RETURN TOMORROW and we’ll look at substudies from #EXPLORER_HCM, at #VALOR_HCM and #MAVERICK_HCM, and we’ll also talk about an emerging medical treatment, #Aficamten. Tomorrow you’ll also get your link to your 🆓CE/#CME!

1

2

1

531

cardio-met

@cardiomet_CE

over 3 years ago

38) Moreover, 10% pts were on #disopyramide & there were no safety signals when the 2 drugs have been coadministered. #VALOR_HCM

cardiomet_CE's tweet photo. 38) Moreover, 10% pts were on #disopyramide & there were no safety signals when the 2 drugs have been coadministered. #VALOR_HCM https://t.co/9ULy8iDh9s

1

3

2

0

378

cardio-met

@cardiomet_CE

over 3 years ago

37) #VALOR_HCM demonstrated even more important result of #mavacamtem in #HOCM, Indeed it significantly reduced the need for #SeptalReductionTherapy. The previous benefits has been confirmed as the safety profile. 👉 https://t.co/pFpnR7KX11

1

3

2

0

408

cardio-met

@cardiomet_CE

over 3 years ago

50) A second phase 3 trial, #VALOR_HCM (presented at #ACC22), recruited patients who were referred to septal reduction therapy based on symptoms (typically NYHA class III/IV) + obstructive LVOT gradient > 50 mm Hg. See https://t.co/6q566MGxEl.

1

2

0

416